T1	Participants 86 151	cryptococcal meningitis in the acquired immunodeficiency syndrome
T2	Participants 219 281	In patients with the acquired immunodeficiency syndrome (AIDS)
T3	Participants 506 676	all participants had sterile cultures of cerebrospinal fluid, blood, and urine after following a standardized course of therapy for culture-proved cryptococcal meningitis
T4	Participants 891 1123	Of 84 patients initially enrolled, 16 (19 percent) were found to have silent, persistent infection on the basis of cultures that became positive after entry into the study; 7 other patients were lost to follow-up shortly after entry
T5	Participants 1132 1153	remaining 61 patients
T6	Participants 2022 2040	patients with AIDS
